Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.527SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.500SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.147SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.487SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.68SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.121SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AS.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.115SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.127.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.88SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.422SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.56SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.198SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.366SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.441SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.416SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.63SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.135SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FK.1.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.219SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
N.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.208SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.78 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.159SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.43.5 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.6.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.443SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.237SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBNSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.356SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.462SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.147SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.6 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.5 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.4 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used